Overview

A Multi-Center Study of Lapatinib in Patients With Trastuzumab-refractory Metastatic Breast Cancer

Status:
Completed
Trial end date:
2020-05-31
Target enrollment:
Participant gender:
Summary
Evaluating the Efficacy of Lapatinib in Combination With Chemotherapy in Patients With Trastuzumab-refractory Metastatic HER2-positive Breast Cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Sun Yat-sen University
Treatments:
Capecitabine
Lapatinib
Vinblastine
Vinorelbine